https://www.prognyx.com/blog/chmp-backs-j-j-s-teclistamab-for-earlier-line-relapsed-refractory-myelomaPrognyxen2026-09-19CHMP backs J J's teclistamab for earlier-line relapsed/refractory myeloma https://www.prognyx.com/blog/cancernetwork-chmp-backed-lifyorli-combo-for-platinum-resistant-ovarian-cancerPrognyxen2026-09-18CancerNetwork: CHMP backed Lifyorli combo for platinum-resistant ovarian cancer